AASLD is actively monitoring events related to the COVID-19 pandemic and will provide timely information and resources to support health care providers in hepatology, liver transplantation and gastroenterology as well as their patients and caregivers. This resource page will be updated regularly as more data become available to the AASLD Leadership.

AASLD's "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic"

This document provides data on what is known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a basic template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and health care providers. This document will continue to evolve and be reviewed by the authors and AASLD Governing Board, and be revised and updated as needed in response to the COVID-19 pandemic.

Read AASLD's Clinical Insights. [Updated: June 25, 2020 | What's New in the June 25 document]

NEW! Read the Spanish version of AASLD's Clinical Insights. [Updated: July 1, 2020. Translation of the June 25, 2020 document.]

Read the Portuguese version of AASLD's Clinical Insights. [Updated: June 30, 2020. Translation of the June 25, 2020 document.]

Upcoming Webinars

Thursday, July 23
AASLD webinar – "AASLD-NASPGHAN-SPLIT COVID-19 & the Liver: Pediatric Perspective"

As the COVID-19 pandemic continues to evolve, it is important for the pediatric hepatology community to understand the liver manifestations in children with SARS-COV2 infection and Multi-System Inflammatory Syndrome in children (MIS-C). In addition, there may be unique susceptibilities in children with chronic liver disease and liver transplantation.

Participants will be able to:

  • Understand liver involvement in SARS-COV2 infection and MIS-C
  • Improve care for children with chronic liver disease and pediatric liver transplant recipients
  • Develop strategies for safe re-entry to clinical practice in pediatric hepatology and transplantation

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, July 21, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Thursday, August 6
AASLD webinar – "COVID-19 & the Liver: Clinical Research in Hepatology during the COVID-19 Pandemic and Beyond"

 

"COVID-19 and the Liver" Webinar Series

In response to the COVID-19 pandemic, AASLD has created a series of webinars dedicated to ongoing discoveries and discussions about how it affects the care of liver patients. These webinars, including those in which we collaborated with sister organizations, are located on the "COVID-19 and the Liver Webinar Series" page.

For the Clinician

  • Joint Society Messages

Joint Society Message: Supplemental Funding for VA Research to Support COVID-19 Research Efforts Needed

Read the joint societies' statement.

Joint Society Message: Use of Personal Protective Equipment in GI Endoscopy

Read the joint societies' statement.

Joint Society Message: Gastroenterology Professional Society Guidance on Endoscopic Procedures during the COVID-19 Pandemic

Read the joint societies' statement.

Joint GI Society Message: COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers

Read the joint GI societies' statement.

AGA issues formal recommendations for PPE during gastrointestinal procedures

Read AGA's recommendations.

AASLD's Clinical and Public Policy Positions

  • The Administration
  • Congress
  • Centers for Disease Control and Prevention
  • Centers for Medicare & Medicaid Services

AASLD joins 200 Organizations in Letter to Administration regarding PPE and Ventilators

Read the joint societies' letter to the Administration.

What You Can Do

  • Actions You Can Take

AASLD seeks COVID-19 Manuscript Submissions

Read the letter from AASLD journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szabo.

COVID-19 Discussion Community in Engage

AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.

Join the conversation.

Write your Congressional Representatives and Senators

Join us and make your voice heard: Use our online advocacy tool to send an email to your legislators about how COVID-19 is impacting you and what needs to be done to protect you, your colleagues and your patients during this urgent time.

 

Journal References for COVID-19

  • AASLD Journal Articles
  • Resources from Other Publishers

HEPATOLOGY

Clinical Liver Disease

Liver Transplantation

Hepatology Communications

Other COVID-19 Resources

  • American Medical Association
  • Centers for Disease Control and Prevention
  • Centers for Medicare and Medicaid Services
  • Fellow Hepatology, GI and Transplant Organizations
  • Food & Drug Administration
  • Health & Human Services
  • Health Care Resiliency Taskforce
  • National Institutes of Health
  • SECURE-Cirrhosis
  • AABB
  • AASLD News
  • For Patients